title: Treatment of molecular relapse in patients with acute myeloid leukemia using clofarabine monotherapy.
abstract: Few studies have examined the treatment of molecular relapse in patients with acute myeloid leukemia (AML) using different treatment regimens. We describe for the first time in the literature experiences with administration of clofarabine monotherapy in the treatment of eight patients with AML with molecular relapse of the disease.
authors: Department of Internal Medicine--Hemato-Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic. zracil@fnbrno.cz
authors: Zdenek
authors: Z
authors: Racil
authors: Martina
authors: M
authors: Toskova
authors: Dana
authors: D
authors: Dvorakova
authors: Ivana
authors: I
authors: Jeziskova
authors: Filip
authors: F
authors: Razga
authors: Lucie
authors: L
authors: Buresova
authors: Shira
authors: S
authors: Timilsina
authors: Jiri
authors: J
authors: Mayer
mesh_terms: D000227:Adenine Nucleotides / Q000494:pharmacology / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001087:Arabinonucleosides / Q000494:pharmacology / Q000627:therapeutic use*; D000077866:Clofarabine; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000235:genetics / Q000401:mortality / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009154:Mutation; D009687:Nuclear Proteins / Q000235:genetics; D000090243:Nucleophosmin; D015514:Oncogene Proteins, Fusion / Q000235:genetics; D012008:Recurrence; D012074:Remission Induction; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D000227:Adenine Nucleotides; D000970:Antineoplastic Agents; D001087:Arabinonucleosides; D009687:Nuclear Proteins; D015514:Oncogene Proteins, Fusion; D000090243:Nucleophosmin; D000077866:Clofarabine